FDAFDA · Food and drugs·Recall number D-0727-2022
Clotrimazole and Betamethasone Dipropionate Cream USP, 1%/0.05%,15 g tubes, Rx only, Manufactured by: Taro Pharmaceuticals Industries Ltd. Haifa Bay, Israel 2624761, Distributed by: Taro Pharmaceuticals U.S.A., Inc. Hawthorne, NY 10532, NDC 51672-4048-1
Published April 6, 2022 · Recall initiated: February 25, 2022
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Content Uniformity Specifications: Out-of-specification result for the Betamethasone Dipropionate assay of a stability sample
What to do
Voluntary: Firm initiated · Letter
Recall details
- Brand
- CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE
- Manufacturer
- Taro Pharmaceuticals U.S.A., Inc.
- Distributor
- Product was distributed to one retail consignee in NY.
- Lot
- Lot #: AC33883, Exp. Date June 2023
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.